-
Markets
athexgroup.grAthens Exchange GroupRead moreTogether for a unified, stronger European capital market.
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureTrade Mini Bond FuturesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Agricultural quotes
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Dairy derivatives
- Salmon derivatives
- Container Freight Futures
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Take control of unpredictable dairy pricesEuropean Dairy DerivativesRead moreFutures and options on butter and skimmed milk powder now trading.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
ERYtech Pharma
Identification
Instrument name
ERYTECH PHARMA
Symbol
ERYPA
ISIN code
FR0011471135
Exchange / Market
Euronext
Trading location
Paris
Products family
Stocks
Capitalization compartment
Compartment C
ICB
Pharmaceuticals
Activity description
ERYtech Pharma est spécialisé dans le développement et la fabrication de produits thérapeutiques destinés au traitement des pathologies graves, des indications orphelines ou des sous-populations de patients notamment dans les domaines de l'hématologie, du cancer et des maladies métaboliques. Par ailleurs, le groupe propose des prestations de recherche et de développement pour compte de tiers.
Source : Cofisem
Website address
http://www.erytech.com
Operation
IPO date
Tue 07/05/2013
IPO type
Introduction par offre au public
Catégorie
IPO
Operation calendar
30 APR 2013 Listing
07 MAY 2013 Trading
Price range
Prix d'émission: 10,50 - 12,70 EUR
Capital raised
17,68